Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03442114 · ClinicalTrials.gov registry record · NA
Shared-Decision Making for Hydroxyurea
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 176
- Enrollment target
NCT03442114 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 176 participants.
The verdict
NCT03442114, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
Study Summary
The goal of the study is to understand how best to help parents of young children with sickle cell disease and their clinicians have a shared discussion about hydroxyurea (one that takes into account medical evidence and parent values and preferences). The study will compare two methods to help clinicians facilitate this-a clinician pocket guide and a clinician hydroxyurea shared decision making toolkit-in a group of parents of children ages 0-5 with sickle cell disease. The investigators hope that both methods lead to parents reaching a high-quality, well-informed decision. In addition, the team hopes to demonstrate that parents who experience a shared decision will have lower anxiety and decisional uncertainty. The researchers also expect these parents to be more likely to choose hydroxyurea and that their children will have less pain, fewer hospitalizations, better developmental outcomes, and higher quality of life. The project team hopes to show that the toolkit method is easy for clinicians to use and gives parents the support needed to make an informed decision.
Interventions
- BEHAVIORAL Hydroxyurea SDM Toolkit
- BEHAVIORAL Clinician Pocket Guide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03442114
The ClinicalTrials.gov registry entry for NCT03442114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydroxyurea SDM Toolkit is the first listed.
NCT03442114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03442114 about?
NCT03442114 is a clinical study titled "Shared-Decision Making for Hydroxyurea". The goal of the study is to understand how best to help parents of young children with sickle cell disease and their clinicians have a shared discussion about hydroxyurea (one that takes into account medical evidence and parent values and preferences). The study will compare two methods to help clin...
What is the current status of trial NCT03442114?
This trial is currently completed. It is a NA study. The enrollment target is 176 participants. The study started on 2018-07-12. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03442114?
The interventions under investigation include: Hydroxyurea SDM Toolkit (BEHAVIORAL), Clinician Pocket Guide (BEHAVIORAL).
Who is sponsoring clinical trial NCT03442114?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.